Form 8-K - Current report:
SEC Accession No. 0001558370-25-000155
Filing Date
2025-01-13
Accepted
2025-01-13 08:00:39
Documents
52
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20250113x8k.htm   iXBRL 8-K 41560
2 EX-99.1 apre-20250113xex99d1.htm EX-99.1 59258
3 GRAPHIC apre-20250113xex99d1g001.jpg GRAPHIC 98543
4 GRAPHIC apre-20250113xex99d1g002.jpg GRAPHIC 313310
5 GRAPHIC apre-20250113xex99d1g003.jpg GRAPHIC 177653
6 GRAPHIC apre-20250113xex99d1g004.jpg GRAPHIC 121918
7 GRAPHIC apre-20250113xex99d1g005.jpg GRAPHIC 133606
8 GRAPHIC apre-20250113xex99d1g006.jpg GRAPHIC 170127
9 GRAPHIC apre-20250113xex99d1g007.jpg GRAPHIC 57333
10 GRAPHIC apre-20250113xex99d1g008.jpg GRAPHIC 208985
11 GRAPHIC apre-20250113xex99d1g009.jpg GRAPHIC 73972
12 GRAPHIC apre-20250113xex99d1g010.jpg GRAPHIC 144563
13 GRAPHIC apre-20250113xex99d1g011.jpg GRAPHIC 213708
14 GRAPHIC apre-20250113xex99d1g012.jpg GRAPHIC 153534
15 GRAPHIC apre-20250113xex99d1g013.jpg GRAPHIC 132941
16 GRAPHIC apre-20250113xex99d1g014.jpg GRAPHIC 131641
17 GRAPHIC apre-20250113xex99d1g015.jpg GRAPHIC 82210
18 GRAPHIC apre-20250113xex99d1g016.jpg GRAPHIC 112412
19 GRAPHIC apre-20250113xex99d1g017.jpg GRAPHIC 56537
20 GRAPHIC apre-20250113xex99d1g018.jpg GRAPHIC 149366
21 GRAPHIC apre-20250113xex99d1g019.jpg GRAPHIC 139692
22 GRAPHIC apre-20250113xex99d1g020.jpg GRAPHIC 97141
23 GRAPHIC apre-20250113xex99d1g021.jpg GRAPHIC 135186
24 GRAPHIC apre-20250113xex99d1g022.jpg GRAPHIC 58325
25 GRAPHIC apre-20250113xex99d1g023.jpg GRAPHIC 130711
26 GRAPHIC apre-20250113xex99d1g024.jpg GRAPHIC 178053
27 GRAPHIC apre-20250113xex99d1g025.jpg GRAPHIC 128710
28 GRAPHIC apre-20250113xex99d1g026.jpg GRAPHIC 169758
29 GRAPHIC apre-20250113xex99d1g027.jpg GRAPHIC 53806
30 GRAPHIC apre-20250113xex99d1g028.jpg GRAPHIC 165941
31 GRAPHIC apre-20250113xex99d1g029.jpg GRAPHIC 114857
32 GRAPHIC apre-20250113xex99d1g030.jpg GRAPHIC 152531
33 GRAPHIC apre-20250113xex99d1g031.jpg GRAPHIC 130428
34 GRAPHIC apre-20250113xex99d1g032.jpg GRAPHIC 128526
35 GRAPHIC apre-20250113xex99d1g033.jpg GRAPHIC 134802
36 GRAPHIC apre-20250113xex99d1g034.jpg GRAPHIC 78355
37 GRAPHIC apre-20250113xex99d1g035.jpg GRAPHIC 162891
38 GRAPHIC apre-20250113xex99d1g036.jpg GRAPHIC 140050
39 GRAPHIC apre-20250113xex99d1g037.jpg GRAPHIC 148739
  Complete submission text file 0001558370-25-000155.txt   7037313

Data Files

Seq Description Document Type Size
40 EX-101.SCH apre-20250113.xsd EX-101.SCH 4091
41 EX-101.DEF apre-20250113_def.xml EX-101.DEF 2846
42 EX-101.LAB apre-20250113_lab.xml EX-101.LAB 16595
43 EX-101.PRE apre-20250113_pre.xml EX-101.PRE 10905
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20250113x8k_htm.xml XML 4677
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 25524872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)